Men would be willing to pay up to $2,000 of their own money to get a more accurate test to detect — or rule out — prostate cancer. This was the outcome of a study that examined how men viewed a technique that — although available — is rarely covered by health insurance plans. The research, “Examining patient’s willingness-to-pay for MRI guided prostate biopsy: Implications in the era of health savings accounts,” was published in the journal Urology Practice. It was a collaborative effort of Loyola Medicine and Loyola University Chicago's